Literature DB >> 19136695

Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus.

Clare C McCormick1, Armando R Caballero, Charles L Balzli, Aihua Tang, Richard J O'Callaghan.   

Abstract

PURPOSE: alpha-Toxin mediates extreme corneal damage during Staphylococcus aureus keratitis. Chemical inhibition of this toxin was sought to provide relief from toxin-mediated pathology.
METHODS: Inhibition of alpha-toxin by phosphate-buffered saline (PBS), 0.1% methyl-beta-cyclodextrin (CD), or CD plus cholesterol (0.1%, CD-cholesterol) was assayed by hemolysis of rabbit erythrocytes. Pathologic changes in rabbit corneas injected with 12 hemolytic units of alpha-toxin suspended in PBS, 1% CD, or 1% CD-cholesterol were compared over time. Rabbit corneas injected with 10(2) colony forming units (CFU) of S. aureus were treated from 7 to 13 hours postinfection (PI) with a total of 15 drops of CD-cholesterol, CD, or PBS. Slit lamp examination (SLE) and measurement of erosions were performed at 13 hours PI and bacteria were quantified at 14 hours PI.
RESULTS: Toxin-mediated lysis of erythrocytes was inhibited up to 16,000-fold in the presence of CD-cholesterol compared with CD or PBS. Eyes injected with alpha-toxin mixed with CD-cholesterol had, at 7 hours postinjection, significantly smaller erosions than eyes injected with alpha-toxin in PBS or alpha-toxin mixed with CD (P = 0.0090 and P = 0.0035, respectively). Eyes infected with S. aureus and treated with CD-cholesterol had significantly lower SLE scores than eyes treated with CD or PBS (P <or= 0.0103 and P <or= 0.0017, respectively); however, there were no differences in the number of bacteria present (P >or= 0.0648).
CONCLUSIONS: CD-cholesterol is a potent inhibitor of alpha-toxin activity in vitro and an effective means to arrest corneal damage during S. aureus keratitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19136695     DOI: 10.1167/iovs.08-3157

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  24 in total

1.  Liposome-like Nanostructures for Drug Delivery.

Authors:  Weiwei Gao; Che-Ming J Hu; Ronnie H Fang; Liangfang Zhang
Journal:  J Mater Chem B       Date:  2013-12-28       Impact factor: 6.331

2.  Staphylococcus aureus Alpha-Toxin Disrupts Endothelial-Cell Tight Junctions via Acid Sphingomyelinase and Ceramide.

Authors:  Björn Fahsel; Hannes Kemper; Joelina Mayeres; Katrin Anne Becker; Cao Li; Barbara Wilker; Simone Keitsch; Matthias Soddemann; Carolin Sehl; Marcus Kohnen; Michael J Edwards; Heike Grassmé; Charles C Caldwell; Aaron Seitz; Martin Fraunholz; Erich Gulbins
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

3.  Hydrogel Retaining Toxin-Absorbing Nanosponges for Local Treatment of Methicillin-Resistant Staphylococcus aureus Infection.

Authors:  Fei Wang; Weiwei Gao; Soracha Thamphiwatana; Brian T Luk; Pavimol Angsantikul; Qiangzhe Zhang; Che-Ming J Hu; Ronnie H Fang; Jonathan A Copp; Dissaya Pornpattananangkul; Weiyue Lu; Liangfang Zhang
Journal:  Adv Mater       Date:  2015-04-30       Impact factor: 30.849

4.  Defining the strain-dependent impact of the Staphylococcal accessory regulator (sarA) on the alpha-toxin phenotype of Staphylococcus aureus.

Authors:  Agnieszka K Zielinska; Karen E Beenken; Hwang-Soo Joo; Lara N Mrak; Linda M Griffin; Thanh T Luong; Chia Y Lee; Michael Otto; Lindsey N Shaw; Mark S Smeltzer
Journal:  J Bacteriol       Date:  2011-04-08       Impact factor: 3.490

5.  Suppression of Staphylococcus aureus virulence by a small-molecule compound.

Authors:  Peng Gao; Pak Leung Ho; Bingpeng Yan; Kong Hung Sze; Julian Davies; Richard Yi Tsun Kao
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-16       Impact factor: 11.205

6.  Phospholipid scramblase 1 mediates type i interferon-induced protection against staphylococcal α-toxin.

Authors:  Miroslaw Lizak; Timur O Yarovinsky
Journal:  Cell Host Microbe       Date:  2012-01-19       Impact factor: 21.023

7.  Syndecan-1 promotes Staphylococcus aureus corneal infection by counteracting neutrophil-mediated host defense.

Authors:  Atsuko Hayashida; Shiro Amano; Pyong Woo Park
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

Review 8.  Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs.

Authors:  Jason Munguia; Victor Nizet
Journal:  Trends Pharmacol Sci       Date:  2017-03-08       Impact factor: 14.819

9.  Prevention and treatment of Staphylococcus aureus pneumonia with a beta-cyclodextrin derivative.

Authors:  Brook E Ragle; Vladimir A Karginov; Juliane Bubeck Wardenburg
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

10.  Staphylococcus aureus alpha-hemolysin impairs corneal epithelial wound healing and promotes intracellular bacterial invasion.

Authors:  Ilham Putra; Behnam Rabiee; Khandaker N Anwar; Sanaz Gidfar; Xiang Shen; Mehrdad Babalooee; Mahmood Ghassemi; Neda Afsharkhamseh; Saaquib Bakhsh; Dominique Missiakas; Ali Nezamabadi; Behrad Milani; Medi Eslani; Ali R Djalilian
Journal:  Exp Eye Res       Date:  2019-02-27       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.